Endometriosis Trial, Recruiting (NCT01301885)

Endometriosis Trial, Recruiting NCT01301885 Sponsor: Turku University Hospital Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT01301885 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

(Study group) You have been diagnosed with endometriosis that has been confirmed through surgery and laboratory examination of tissue samples.
(Control group) You have had a keyhole surgery (laparoscopy) that confirmed you do not have endometriosis.

Who may not be able to join:

You have another serious health condition or are taking medication for another illness.
There is any concern or suspicion that you may have cancer.
You are currently pregnant.
You have an active infection at the time of the study.
You do not have a sufficient understanding of the Finnish language.
You have previously had surgery to remove your womb (hysterectomy) and/or both ovaries and fallopian tubes (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Antti Perheentupa, MD, PhD, Department of Obstetrics and Gynecology, Turku University Central Hospital

Phone: +358-2-3130000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01301885

Sponsor: Turku University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Endometriosis

Trial contact: +358-2-3130000

More information: https://clinicaltrials.gov/study/NCT01301885

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

(Study group) You have been diagnosed with endometriosis that has been confirmed through surgery and laboratory examination of tissue samples.
(Control group) You have had a keyhole surgery (laparoscopy) that confirmed you do not have endometriosis.

Who may not be able to join:

You have another serious health condition or are taking medication for another illness.
There is any concern or suspicion that you may have cancer.
You are currently pregnant.
You have an active infection at the time of the study.
You do not have a sufficient understanding of the Finnish language.
You have previously had surgery to remove your womb (hysterectomy) and/or both ovaries and fallopian tubes (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Turku University Hospital

Registry

ClinicalTrials.gov

Start date

1 October 2005

Est. completion

1 December 2025

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Intra-tissue steroid profiling indicates differential progesterone and testosterone metabolism in the endometrium and endometriosis lesions.; Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels.; Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts.; A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov